Lahore Chemical and Pharmaceutical Works products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Lahore · Pakistan
Lahore pharmaceutical manufacturer and exporter with products represented on Pakistan's official Trade Portal.
Lahore Chemical and Pharmaceutical Works products in Pakistan
Lahore Chemical and Pharmaceutical Works Pvt. Ltd has 40 medicine presentations registered in Pakistan under 29 brands, covering 27 generic medicines. Most of its products are in Anti-infectives, Anesthesia & critical care and Cardiovascular. Its brands with the most registered strengths and packs are Florocin (Ciprofloxacin), Gentamicin (Gentamicin), Bupicain (Bupivacaine) and Cimonil (Cefixime). 40 products have an official DRAP price on MedInfoBase. See all 29 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Lahore Chemical and Pharmaceutical Works (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- 137, Shahrah Maulana Jalaluddin Roomi, Lahore, Pakistan
- Phone
- +92 334 4333378
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 63%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Lahore Chemical and Pharmaceutical Works Pvt. Ltd. is priced against the market
31 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Arnot Eye DropsRegistry verified | Tobramycin | — | — | — | 052467Official source ↗ | No indexed price | — | — |
| Bupicain | Bupivacaine | 50 mg/10 mL | Injection | 1x10ml | 007268 | PKR 44.01 | PKR 4.40/mL | No comparator |
| Bupicain | Bupivacaine | 15 mg/2 mL | Injection | 5x2ml | 025856 | PKR 401.66 | PKR 40.17/mL | No comparator |
| Ceflum Injection 1gm (IM/IV)Registry verified | Cefepime hydrochloride eq to cefepime (with L-arginine) | — | — | — | 101681Official source ↗ | No indexed price | — | — |
| Ceflum Injection 500mg (IM/IV)Registry verified | Cefepime as HCl with L-arginine eq. to Cefipime | — | — | — | 101680Official source ↗ | No indexed price | — | — |
| CeftacinSource observed | Ceftazidime | 500 mg | Injection | Vial | 028131Official source ↗ | No indexed price | — | — |
| Ceftacin | Ceftazidime | 1 g | Injection | Vial | 028133 | PKR 479.56 | PKR 479.56/vial/unit | 🔒 Pharma Pro |
| Chloramphenicol | Chloramphenicol | 250 mg | Capsule | 12's | 005584 | PKR 66.21 | PKR 5.52/capsule | No comparator |
| Cimonil | Cefixime | 400 mg | Capsule | 1x5's | 021686 | PKR 592.03 | PKR 118.41/capsule | 🔒 Pharma Pro |
| Cimonil | Cefixime | 100 mg/5 mL | Suspension | 30ml | 021687 | PKR 330.40 | PKR 11.01/mL | 🔒 Pharma Pro |
| Clofer | Clomifene citrate | 50 mg | Tablet | 3x10's | 005507 | PKR 1,536.23 | PKR 51.21/tablet | 🔒 Pharma Pro |
| Cytotrexate | Methotrexate | 2.5 mg | Tablet | 100's(Bottle) | 008759 | PKR 3,104.91 | PKR 31.05/tablet | 🔒 Pharma Pro |
| Dopamine | Dopamine HCl | 200 mg/5 mL | Injection | 1x5ml | 005935 | PKR 207.16 | PKR 41.43/mL | No comparator |
| Florocin | Ciprofloxacin | 2 mg/mL (200 mg/100 mL) | Injection | 50ml | 021683 | PKR 309.80 | PKR 6.20/mL | No comparator |
| Florocin | Ciprofloxacin | 250 mg | Tablet | 1x10's | 027909 | PKR 351.10 | PKR 35.11/tablet | 🔒 Pharma Pro |
| Florocin | Ciprofloxacin | 500 mg | Tablet | 1x10's | 027910 | PKR 619.59 | PKR 61.96/tablet | 🔒 Pharma Pro |
| Florocin | Ciprofloxacin | 250 mg/5 mL | Dry suspension | 60ml | 108439 | PKR 240.11 | PKR 4.00/mL | 🔒 Pharma Pro |
| Florocin 125mg/5ml SuspensionRegistry verified | Ciprofloxacin | — | — | — | 108438Official source ↗ | No indexed price | — | — |
| Florocin Suspention | Ciprofloxacin | 250 mg/5 mL | Suspension | 120ml | 108439 | PKR 360.16 | PKR 3.00/mL | 🔒 Pharma Pro |
| Fursemide | Furosemide | 40 mg | Tablet | 10x10's | 001749 | PKR 406.02 | PKR 4.06/tablet | 🔒 Pharma Pro |
| Gentamicin | Gentamicin | 40 mg/mL | Injection | 3x1ml | 004609 | PKR 93.63 | PKR 31.21/mL | 🔒 Pharma Pro |
| Gentamicin | Gentamicin | 40 mg/mL | Injection | 2x2ml | 004609 | PKR 106.84 | PKR 26.71/mL | 🔒 Pharma Pro |
| Gentamicin | Gentamicin | 0.3 % | Ophthalmic drops | 10ml | 006665 | PKR 37.51 | PKR 3.75/mL | 🔒 Pharma Pro |
| Gomal | Quinine dihydrochloride | 300 mg/mL | Injection | 50'sx1ml | 028136 | PKR 748.74 | PKR 14.97/mL | No comparator |
| Irriceta 1gm/100ml InfusionRegistry verified | Paracetamol | — | — | — | 108435Official source ↗ | No indexed price | — | — |
| Ketocain | Ketamine | 100 mg/2 mL | Injection | 1x2ml | 095865 | PKR 42.21 | PKR 21.11/mL | No comparator |
| Levopath | Levofloxacin | 250 mg | Tablet | 10's | 069469 | PKR 351.10 | PKR 35.11/tablet | 🔒 Pharma Pro |
| Levopath | Levofloxacin | 500 mg | Tablet | 10's | 069470 | PKR 557.63 | PKR 55.76/tablet | 🔒 Pharma Pro |
| Libor | Ceftriaxone | 250 mg | Injection | Vial | 026243 | PKR 227.18 | PKR 227.18/vial/unit | 🔒 Pharma Pro |
| Libor | Ceftriaxone | 1 g | Injection | Vial | 026244 | PKR 660.90 | PKR 660.90/vial/unit | 🔒 Pharma Pro |
| Libor Injection 500mgRegistry verified | Ceftriaxone | — | — | — | 027577Official source ↗ | No indexed price | — | — |
| Lignocaine | Lidocaine | 2 % | Gel | 15gm | 004875 | PKR 15.12 | PKR 1.01/g | No comparator |
| Metformin HCl | Metformin | 500 mg | Tablet | 5x10's | 012598 | PKR 157.33 | PKR 3.15/tablet | 🔒 Pharma Pro |
| MFX | Moxifloxacin | 400 mg | Tablet | 5's | 102587 | PKR 762.72 | PKR 152.54/tablet | 🔒 Pharma Pro |
| Opidep | Naloxone | 0.4 mg/mL | Injection | 1's | 099851 | PKR 168.60 | PKR 168.60/vial/unit | 🔒 Pharma Pro |
| Patzon Eye Drops 0.2%Registry verified | Olopatadine as Hydrochloride | — | — | — | 109292Official source ↗ | No indexed price | — | — |
| Plasmomef | Artemether | 80 mg | Injection | 1mlx6's | 085211 | PKR 1,026.24 | PKR 171.04/mL | 🔒 Pharma Pro |
| Plasmomef | Artemether | 120 mg | Tablet | 2x8's | 085212 | PKR 651.58 | PKR 40.72/tablet | 🔒 Pharma Pro |
| Prednisolone | Prednisolone | 5 mg | Tablet | 1000's | 003440 | PKR 3,586.47 | PKR 3.59/tablet | 🔒 Pharma Pro |
| Protamine Sulphate | Protamine Sulphate | 50 mg | Injection | 10x5ml | 006121 | PKR 2,182.25 | PKR 43.65/mL | No comparator |
| Protokef 500 IM InjectionRegistry verified | Ceftriaxone | — | — | — | 010253Official source ↗ | No indexed price | — | — |
| Quinine Bi-Sulphate | Quinine bisulfate | 300 mg | Tablet | 100's | 001766 | PKR 98.74 | PKR 0.99/tablet | 🔒 Pharma Pro |
| Salmone | Amlodipine | 5 mg | Tablet | 2x10's | 023935 | PKR 268.49 | PKR 13.42/tablet | 🔒 Pharma Pro |
| Setex | Cefotaxime | 250 mg | IM/IV injection | Vial | 022217 | PKR 110.88 | PKR 110.88/vial/unit | 🔒 Pharma Pro |
| Trop | Ciprofloxacin | 0.3 % | Ophthalmic drops | 5ml | 052466 | PKR 196.20 | PKR 39.24/mL | 🔒 Pharma Pro |
| Warocin | Warfarin | 5 mg | Tablet | 100's | 016856 | PKR 1,797.34 | PKR 17.97/tablet | 🔒 Pharma Pro |
| Zipo | Hydrocortisone | 100 mg | Injection | Vial | 005796 | PKR 131.73 | PKR 131.73/vial/unit | 🔒 Pharma Pro |
| Zorix | Azithromycin | 200 mg/5 mL | Suspension | 15ml | 028134 | PKR 328.27 | PKR 21.88/mL | 🔒 Pharma Pro |
| Zorix | Azithromycin | 250 mg | Capsule | 6's | 028135 | PKR 402.40 | PKR 67.07/capsule | 🔒 Pharma Pro |
All 29 Lahore Chemical and Pharmaceutical Works brands in Pakistan
- Bupicain Bupivacaine · 15 mg/2 mL injection, 50 mg/10 mL injection
- Ceftacin Ceftazidime · 1 g injection
- Chloramphenicol Chloramphenicol · 250 mg capsule
- Cimonil Cefixime · 100 mg/5 mL suspension, 400 mg capsule
- Clofer Clomifene citrate · 50 mg tablet
- Cytotrexate Methotrexate · 2.5 mg tablet
- Dopamine Dopamine HCl · 200 mg/5 mL injection
- Florocin Ciprofloxacin · 2 mg/mL (200 mg/100 mL) injection, 250 mg tablet, 250 mg/5 mL suspension
- Florocin Suspention Ciprofloxacin · 250 mg/5 mL suspension
- Fursemide Furosemide · 40 mg tablet
- Gentamicin Gentamicin · 0.3 % drops, 40 mg/mL injection
- Gomal Quinine dihydrochloride · 300 mg/mL injection
- Ketocain Ketamine · 100 mg/2 mL injection
- Levopath Levofloxacin · 250 mg tablet, 500 mg tablet
- Libor Ceftriaxone · 1 g injection, 250 mg injection
- Lignocaine Lidocaine · 2 % gel
- Metformin HCl Metformin · 500 mg tablet
- MFX Moxifloxacin · 400 mg tablet
- Opidep Naloxone · 0.4 mg/mL injection
- Plasmomef Artemether · 120 mg tablet, 80 mg injection
- Prednisolone Prednisolone · 5 mg tablet
- Protamine Sulphate Protamine Sulphate · 50 mg injection
- Quinine Bi-Sulphate Quinine bisulfate · 300 mg tablet
- Salmone Amlodipine · 5 mg tablet
- Setex Cefotaxime · 250 mg injection
- Trop Ciprofloxacin · 0.3 % drops
- Warocin Warfarin · 5 mg tablet
- Zipo Hydrocortisone · 100 mg injection
- Zorix Azithromycin · 200 mg/5 mL suspension, 250 mg capsule
Lahore Chemical and Pharmaceutical Works: common questions
How many products does Lahore Chemical and Pharmaceutical Works have in Pakistan?
Lahore Chemical and Pharmaceutical Works Pvt. Ltd has 40 registered medicine presentations in Pakistan, sold under 29 brands and covering 27 generic medicines.
What are the main brands of Lahore Chemical and Pharmaceutical Works?
By number of registered strengths and packs, its largest brands are Florocin (Ciprofloxacin), Gentamicin (Gentamicin), Bupicain (Bupivacaine), Cimonil (Cefixime) and Levopath (Levofloxacin). This is not a sales ranking.
Which therapy areas does Lahore Chemical and Pharmaceutical Works cover?
The most products are in Anti-infectives (25), Anesthesia & critical care (5), Cardiovascular (3), Hematology & thrombosis (2) and Reproductive & genitourinary (1).
Where can I see Lahore Chemical and Pharmaceutical Works medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.